Remove Copying Remove Document Remove Invention Remove Public Use
article thumbnail

Printed Publication: Documents Made Available only to Customers

Patently-O

The 1836 Patent Act added the caveat that no patent should issue on an invention previously “described in any printed publication.” A new petition asks the court to examine the phrase again and help define when a document crosses the publication threshold. 102(a)(1). Centripetal Networks, Inc.

article thumbnail

Patent Opposition in India

Biswajit Sarkar Copyright Blog

They are as follows: The invention is wrongfully obtained. Publication of invention before the priority date. Prior claiming of invention in other specification. Invention is publicly known or publicly used in India. Invention is obvious and lacks any inventive step. Filing documents.

Patent 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“What’s Mine Is Not Yours To Give Me”—Nor To Take Without Just Compensation: A New Jersey’s Reaction To Sovereign Immunity, Intellectual Property, & Takings

LexBlog IP

And, it goes like this–the relevant concept in the United States is that a person shall “ no[t] be deprived of life, liberty, or property, without due process of law; nor shall private property be taken for public use, without just compensation.” Wright , 94 U.S. ”); James v. Campbell , 104 U.S. 2d 480 (Fed.

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

As of March 23, 2020, Mylan’s NDA for Semglee™ was “deemed” to be a BLA, and Mylan has announced its submission of “all necessary documentation” to FDA for approval of Semglee™ as a biosimilar and interchangeable biosimilar product. Market uptake of biosimilars has generally trended upwards in 2020. Not yet launched. etanercept).